CORTNEY MAHONY: Open Payments
NPI 1639692916 · EMPORIA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 36 payments from 14 companies in 2025. Trend: 2023 $590 · 2024 $1,171 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $237 |
| Novartis Pharmaceuticals Corporation | 5 | $86 |
| Xeris Pharmaceuticals, Inc. | 3 | $67 |
| Novo Nordisk Inc | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Corcept Therapeutics | 3 | $50 |
| Lilly USA, LLC | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $37 |
| Amgen Inc. | 2 | $35 |
Products named: FARXIGA, BREZTRI, LEQVIO, GVOKE HYPOPEN, Kerendia, Korlym, MOUNJARO, REXULTI.
Industry payments across KS — which companies pay providers there.
